Novus Proximus: Patients + Profitability™, Applied | Life Sciences Profitability Advisory

Описание: Novus Proximus is a profitability advisory firm for life sciences, with a heavy lean on Gross-to-Net. The name is Latin for "the New Next."

We work with pharmaceutical and biotech manufacturers of every size, from Pre-Launch and Launch Readiness through Lifecycle and Loss of Exclusivity. Every engagement starts from one idea: patient friction creates revenue leakage.

Three levers of profitability:

• Patient Services. Follow the patient. Where patients leave the journey between diagnosis and therapy initiation, and the support architecture that intervenes.
• Market Access. Follow the conditions. Formulary position, utilization management, affordability and channel decide whether coverage becomes actual therapy.
• Finance and Gross-to-Net. Follow the outcome. We work backward from the number to the commercial and patient events that produced it.

The philosophy behind every engagement is Patients + Profitability™. Patient outcomes and sustainable profitability are interdependent, not opposing.

Better Access. Better Outcomes. Better Business.

Learn more and request a read: https://novusproximus.com
Founder and CEO: Patrick R. Coyle, https://patrickrcoyle.com
Patients + Profitability™ podcast: https://patientsplusprofitability.buz...

#GrossToNet #MarketAccess #PatientServices